Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
作者： Thierry Poynard , Françoise Imbert-Bismut , Mona Munteanu , Djamila Messous , Robert P Myers
关键词:
摘要: Background Recent studies strongly suggest that due to the limitations and risks of biopsy, as well improvement diagnostic accuracy biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT), a panel was found have high value for fibrosis (FT range 0.00–1.00) necroinflammatory histological activity (AT 0.00–1.00). The aim summarize these tests from scientific literature; respond frequently asked questions by performing original new analyses (including values, comparison other impact genotype viral load, intermediate levels injury); develop system conversion between estimates injury.
biomedcentral.com
springer.com
paperity.org参考文章(33)
Robert P Myers, Mercedes De Torres, Françoise Imbert-Bismut, Vlad Ratziu, Frédéric Charlotte, Thierry Poynard, None, Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Digestive Diseases and Sciences. ,vol. 48, pp. 146- 153 ,(2003) , 10.1023/A:1021702902681
Thierry Poynard, Vlad Ratziu, Pierre Bedossa, Appropriateness of liver biopsy. Canadian Journal of Gastroenterology & Hepatology. ,vol. 14, pp. 543- 548 ,(2000) , 10.1155/2000/107982
Sophie Le Calvez, Dominique Thabut, Djamila Messous, Mona Munteanu, Vlad Ratziu, Francoise Imbert-Bismut, Thierry Poynard, The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C Hepatology. ,vol. 39, pp. 862- 863 ,(2004) , 10.1002/HEP.20099
Thierry Poynard, John McHutchison, Michael Manns, Rob P Myers, Janice Albrecht, Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa‐2b and ribavirin Hepatology. ,vol. 38, pp. 481- 492 ,(2003) , 10.1053/JHEP.2003.50319
Nikolaos T. Pyrsopoulos, Eugene R. Schiff, Lennox J. Jeffers, Arie Regev, Enrique G. Molina, K. Rajender Reddy, Zheng Zhou Feng, Clara Milikowski, Mariana Berho, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection The American Journal of Gastroenterology. ,vol. 97, pp. 2614- 2618 ,(2002) , 10.1016/S0002-9270(02)04396-4
Yoshikazu Murawaki, Yujiro Ikuta, Kinya Okamoto, Masahiko Koda, Hironaka Kawasaki, Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. Journal of Gastroenterology. ,vol. 36, pp. 399- 406 ,(2001) , 10.1007/S005350170084
T. Poynard, P. Bedossa, , , Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus Journal of Viral Hepatitis. ,vol. 4, pp. 199- 208 ,(1997) , 10.1046/J.1365-2893.1997.00141.X
P Halfon, M Bourliere, R Deydier, I Portal, C Renou, JJ Bertrand, A Tran, A Rosenthal, M Rotily, A Sattonet, D Ouzan, 68 Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C Hepatology. ,vol. 38, pp. 188- 188 ,(2003) , 10.1016/S0270-9139(03)80111-8
Guido Colloredo, Maria Guido, Aurelio Sonzogni, Gioacchino Leandro, Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease Journal of Hepatology. ,vol. 39, pp. 239- 244 ,(2003) , 10.1016/S0168-8278(03)00191-0
Pierre Bedossa, Delphine Dargere, Valerie Paradis, Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. ,vol. 38, pp. 1449- 1457 ,(2003) , 10.1016/J.HEP.2003.09.022